1. Gregory A, Hayflick SJ. Pantothenate kinase-associated neurodegeneration. In : Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, editors. GeneReviews. Seattle: University of Washington;1993.
2. McCarty SF, Gaebler-Spira D, Harvey RL. Improvement of sleep apnea in a patient with cerebral palsy. Am J Phys Med Rehabil. 2001; 80:540–542.
Article
3. Marchese-Ragona R, Vianello A, Restivo DA, Pittoni G, Lionello M, Martini A, et al. Sleep-related adductor laryngeal dystonia causing sleep apnea: a sleep-related breathing disorder diagnosed with sleep endoscopy and treated with botulinum toxin. Laryngoscope. 2013; 123:1560–1563.
4. Koo DL, Nam H, Thomas RJ, Yun CH. Sleep disturbances as a risk factor for stroke. J Stroke. 2018; 20:12–32.
Article
5. Fantini ML, Cossu G, Molari A, Cabinio M, Uyanik O, Cilia R, et al. Sleep in genetically confirmed pantothenate kinase-associated neurodegeneration: a video-polysomnographic study. Parkinsons Dis. 2010; 2010:342834.
Article
6. Hogarth P, Kurian MA, Gregory A, Csányi B, Zagustin T, Kmiec T, et al. Consensus clinical management guideline for pantothenate kinase-associated neurodegeneration (PKAN). Mol Genet Metab. 2017; 120:278–287.
Article